Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL80 (Dbl naloxone, Nalone, Naloxone, Narcan, Narcanti, NSC-70413, Suboxone) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
A1 receptor/Adenosine A1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL226] [GtoPdb: 18] [UniProtKB: P30542] | ||||||||
ChEMBL | Binding affinity to adenosine receptor A1 | B | 4.3 | pKi | >50000 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 6736-6739 [PMID:19836950] |
CCR5/C-C chemokine receptor type 5 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3676] [GtoPdb: 62] [UniProtKB: P51682] | ||||||||
ChEMBL | Binding affinity to CCR5 in C57BL/6J mouse brain membrane | B | 7.68 | pKd | 20.8 | nM | Kd | Proc Natl Acad Sci U S A (2007) 104: 6061-6065 [PMID:17389363] |
ChEMBL | Binding affinity to CCR5 in NY1DD transgenic mouse brain membrane | B | 7.98 | pKd | 10.5 | nM | Kd | Proc Natl Acad Sci U S A (2007) 104: 6061-6065 [PMID:17389363] |
CYP2D6/Cytochrome P450 2D6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL289] [GtoPdb: 1329] [UniProtKB: P10635] | ||||||||
ChEMBL | DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | B | 5.7 | pIC50 | 2000 | nM | IC50 | DrugMatrix in vitro pharmacology data |
δ receptor/Delta opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL236] [GtoPdb: 317] [UniProtKB: P41143] | ||||||||
ChEMBL | Displacement of [3H]DPDPE from human DOR expressed in HEK293 cells after 60 mins by scintillation counting analysis | B | 5.82 | pKi | 1516 | nM | Ki | J Med Chem (2014) 57: 8903-8927 [PMID:25268943] |
ChEMBL | DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) | B | 6.29 | pKi | 515 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | Displacement of [3H]Naltrindole form human delta opioid receptor expressed in CHO cells | B | 6.92 | pKi | 120 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 203-208 [PMID:19027293] |
ChEMBL | Displacement of [3H]diprenorphine human delta opioid receptor expressed in CHO cell membranes after 1 hr by micro beta2 scintillation counting method | B | 6.92 | pKi | 120 | nM | Ki | ACS Med Chem Lett (2020) 11: 720-726 [PMID:32435376] |
ChEMBL | Displacement of [3H]deltrophine from human delta opioid receptor expressed in CHO-K1 cells after 120 mins by liquid scintillation counting method | B | 6.99 | pKi | 103 | nM | Ki | Medchemcomm (2016) 7: 317-326 |
ChEMBL | Displacement of [3H]-deltorphine from human delta opioid receptor expressed in CHO-K1 cells by scintillation counting analysis | B | 6.99 | pKi | 103 | nM | Ki | J Med Chem (2014) 57: 6845-6860 [PMID:25062506] |
ChEMBL | Displacement of [3H]-diprenorphine from human delta opioid receptor expressed in CHO cell membranes incubated for 1 hr by competition radioligand binding assay | B | 7.01 | pKi | 98.1 | nM | Ki | J Med Chem (2020) 63: 7663-7694 [PMID:32530286] |
ChEMBL | Displacement of [3H]naltrindole from human opioid delta receptor expressed in CHO cells | B | 7.12 | pKi | 76 | nM | Ki | J Med Chem (2007) 50: 2254-2258 [PMID:17407276] |
ChEMBL | Displacement of [3H]-diprenorphine from human DOR expressed in CHO cell membranes incubated for 1 hr by scintillation counting method | B | 7.14 | pKi | 72.8 | nM | Ki | J Med Chem (2020) 63: 2673-2687 [PMID:31834798] |
ChEMBL | Displacement of [3H]-diprenorphine from human delta opioid receptor expressed in CHO cell membranes incubated for 1 hr by micro beta2 scintillation counting method | B | 7.15 | pKi | 70 | nM | Ki | ACS Med Chem Lett (2019) 10: 450-456 [PMID:30996778] |
ChEMBL | Displacement of [125I]OXY from human delta opioid receptor expressed in CHO cells | B | 7.29 | pKi | 51 | nM | Ki | J Med Chem (2010) 53: 1392-1396 [PMID:20055417] |
ChEMBL | Displacement of [3H]DPDPE from delta opioid receptor | B | 7.37 | pKi | 42.6 | nM | Ki | J Nat Prod (1993) 56: 441-455 [PMID:8496700] |
ChEMBL | Inhibition of [3H]naltrindole binding to human Opioid receptor delta 1 in CHO cells | B | 7.39 | pKi | 41 | nM | Ki | Bioorg Med Chem Lett (2000) 10: 523-526 [PMID:10741545] |
ChEMBL | Displacement of [3H]naltrindole from human delta-opioid receptor expressed in CHO cells after 3 hrs by scintillation counting | B | 7.42 | pKi | 38 | nM | Ki | Bioorg Med Chem (2011) 19: 2808-2816 [PMID:21482470] |
ChEMBL | In vitro binding affinity to human Opioid receptor delta 1 on CHO cell membranes using [3H]diprenorphine displacement. | B | 7.43 | pKi | 37 | nM | Ki | J Med Chem (2003) 46: 2104-2109 [PMID:12747782] |
ChEMBL | Concentration required to inhibit the binding of the non-selective opioid antagonist, [3H]diprenorphine, to cloned human delta opioid receptor | B | 7.48 | pKi | 33 | nM | Ki | Bioorg Med Chem Lett (2003) 13: 4459-4462 [PMID:14643346] |
ChEMBL | Displacement of [3H]diprenorphine from human cloned delta opioid receptor | B | 7.48 | pKi | 33 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 2006-2012 [PMID:18313920] |
ChEMBL | Displacement of [3H]diprenorphine from human cloned delta opioid receptor expressed in CHO cells | B | 7.48 | pKi | 33 | nM | Ki | J Med Chem (2006) 49: 7278-7289 [PMID:17149858] |
ChEMBL | Displacement of [3H]diprenorphine from human cloned delta opioid receptor expressed in CHO cells | B | 7.48 | pKi | 33 | nM | Ki | J Med Chem (2006) 49: 7290-7306 [PMID:17149859] |
ChEMBL | Displacement of [3H]DPDPE from delta opioid receptor (unknown origin) transfected into HEK293 cells by microplate scintillation counting | B | 7.52 | pKi | 30 | nM | Ki | J Nat Prod (2015) 78: 1461-1465 [PMID:26035635] |
ChEMBL | Displacement of [3H]DPN from human recombinant delta-type opioid receptor expressed in CHO cell membranes | B | 7.67 | pKi | 21.38 | nM | Ki | Bioorg Med Chem (2009) 17: 5080-5095 [PMID:19527931] |
ChEMBL | In vivo binding affinity against delta Opioid receptor was measured by using labeled ligand [3H]DADLE (1 nM) with 4 nM sufentanil | B | 7.72 | pKi | 19 | nM | Ki | J Med Chem (1994) 37: 3121-3127 [PMID:7932535] |
ChEMBL | Binding affinity to delta-opioid receptor (unknown origin) | B | 7.8 | pKi | 15.85 | nM | Ki | J Nat Prod (2021) 84: 713-723 [PMID:32870011] |
ChEMBL | DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) | B | 5.84 | pIC50 | 1461 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ChEMBL | Antagonist activity at human delta opioid receptor expressed in CHO cell membranes assessed as reduction in SNC80-induced [35S]GTPgammaS binding preincubated for 5 mins followed by SNC80 addition and measured after 1 hr | F | 6.82 | pIC50 | 153 | nM | IC50 | J Med Chem (2020) 63: 7663-7694 [PMID:32530286] |
ChEMBL | Binding affinity against delta-opiate receptor (human) using [3H]-DPDPE radioligand | B | 6.82 | pIC50 | 151 | nM | IC50 | J Med Chem (2001) 44: 3378-3390 [PMID:11585443] |
ChEMBL | Antagonist activity at human delta opioid receptor expressed in CHO cell membranes assessed as reduction in SNC80-induced [35S]GTPgammaS binding incubated for 1 hr | F | 6.84 | pIC50 | 146 | nM | IC50 | ACS Med Chem Lett (2019) 10: 450-456 [PMID:30996778] |
ChEMBL | Displacement of [125I]deltorphin 2 from human recombinant delta opioid receptor expressed in HEK cell membrane | B | 6.86 | pIC50 | 138 | nM | IC50 | J Nat Prod (2007) 70: 866-868 [PMID:17388627] |
ChEMBL | Displacement of [125I]deltorphin 2 from human recombinant delta opioid receptor expressed in HEK cells | B | 6.86 | pIC50 | 138 | nM | IC50 | J Nat Prod (2007) 70: 1946-1950 [PMID:18039010] |
ChEMBL | Displacement of [125I]deltorphin 2 from human recombinant delta opioid receptor expressed in HEK293 cells | B | 6.86 | pIC50 | 138 | nM | IC50 | J Nat Prod (2006) 69: 1295-1299 [PMID:16989522] |
ChEMBL | Displacement of [125I]deltorphin 2 from human recombinant delta opioid receptor expressed in HEK cell membranes | B | 6.86 | pIC50 | 138 | nM | IC50 | J Nat Prod (2007) 70: 872-875 [PMID:17451272] |
ChEMBL | Antagonist activity at human DOR expressed in CHO cell membranes assessed as reduction in SNC80-induced response incubated for 1 hr by [35S]-GTPgammaS coupling assay | F | 7.11 | pIC50 | 78.2 | nM | IC50 | J Med Chem (2020) 63: 2673-2687 [PMID:31834798] |
ChEMBL | Inhibition of Opioid receptor delta 1 by displacing 1 nM [3H]DPDPE in guinea pig brain membrane | B | 7.21 | pIC50 | 62 | nM | IC50 | J Med Chem (1992) 35: 4589-4594 [PMID:1335078] |
ChEMBL | Inhibition of [3H]DPDPE binding to guinea pig brain membrane Opioid receptor delta 1 at 1.0 nM | B | 7.21 | pIC50 | 62 | nM | IC50 | J Med Chem (1992) 35: 2374-2384 [PMID:1320121] |
δ receptor/Delta opioid receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3222] [GtoPdb: 317] [UniProtKB: P32300] | ||||||||
ChEMBL | Tested for inhibitory activity against (DPDE)delta receptor in mouse vas deferens | B | 7.3 | pKd | 50.12 | nM | Kd | J Med Chem (1994) 37: 2262-2265 [PMID:8057274] |
ChEMBL | Antagonist activity at delta opioid receptor in Swiss mouse vas deferens assessed as reversal of DSLET effect on electrically-induced driven twitch | F | 7.35 | pKd | 44.67 | nM | Kd | Bioorg Med Chem (2008) 16: 869-873 [PMID:17962026] |
δ receptor/Delta opioid receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL269] [GtoPdb: 317] [UniProtKB: P33533] | ||||||||
ChEMBL | Affinity against the Opioid receptor delta 1 | B | 7.74 | pKd | 18 | nM | Kd | J Med Chem (1986) 29: 531-537 [PMID:3007760] |
ChEMBL | Displacement of [3H]DPDPE from DOR in Sprague-Dawley rat brain membranes after 120 mins by scintillation counting method | B | 6.99 | pKi | 103 | nM | Ki | J Med Chem (2019) 62: 893-907 [PMID:30543421] |
ChEMBL | Binding affinity towards delta-opioid receptor by displacement of [3H]DADL in rat brain homogenates | B | 7.49 | pKi | 32 | nM | Ki | J Med Chem (1993) 36: 2842-2850 [PMID:8410999] |
ChEMBL | Displacement of [3H]-DPDPE from delta opioid receptor in rat brain membrane after 120 mins by scintillation counting | B | 8.6 | pKi | 2.5 | nM | Ki | Bioorg Med Chem Lett (2015) 25: 5326-5330 [PMID:26411794] |
ChEMBL | Displacement of [3H]DPDPE from delta opioid receptor in Sprague-Dawley rat brain membranes after 120 mins by scintillation counting analysis | B | 8.62 | pKi | 2.4 | nM | Ki | Medchemcomm (2016) 7: 2368-2380 |
ChEMBL | Displacement of [3H]DPDPE from delta opioid receptor in rat membranes after 120 mins by scintillation counting analysis | B | 8.62 | pKi | 2.4 | nM | Ki | J Med Chem (2019) 62: 4204-4217 [PMID:30939014] |
D3 receptor/Dopamine D3 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3138] [GtoPdb: 216] [UniProtKB: P19020] | ||||||||
ChEMBL | Tested for binding affinity against dopamine receptor D3 expressed in Sf9 cells. | B | 4.7 | pKi | >20000 | nM | Ki | J Med Chem (1993) 36: 1499-1500 [PMID:8098771] |
κ receptor/Kappa opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL237] [GtoPdb: 318] [UniProtKB: P41145] | ||||||||
ChEMBL | Displacement of [3H]U-69593 from human KOR expressed in HEK293 cells after 60 mins by scintillation counting analysis | B | 6.44 | pKi | 362 | nM | Ki | J Med Chem (2014) 57: 8903-8927 [PMID:25268943] |
ChEMBL | DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) | B | 7.52 | pKi | 30 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | Binding affinity to kappa-opioid receptor (unknown origin) | B | 7.8 | pKi | 15.85 | nM | Ki | J Nat Prod (2021) 84: 713-723 [PMID:32870011] |
ChEMBL | Displacement of [3H]Cl-977 from human kappa opioid receptor expressed on HEK-293 cells by liquid scintillation counting method | B | 7.82 | pKi | 15 | nM | Ki | Medchemcomm (2016) 7: 317-326 |
ChEMBL | Displacement of [3H]Cl977 from human kappa opioid receptor expressed in HEK293 cells | B | 7.83 | pKi | 14.7 | nM | Ki | J Med Chem (2010) 53: 4212-4222 [PMID:20441176] |
ChEMBL | In vitro binding affinity towards human Opioid receptor kappa 1 on CHO cell membranes using [3H]diprenorphine displacement. | B | 7.97 | pKi | 10.7 | nM | Ki | J Med Chem (2003) 46: 2104-2109 [PMID:12747782] |
ChEMBL | Displacement of [3H]diprenorphine from human cloned kappa opioid receptor | B | 8.04 | pKi | 9.2 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 2006-2012 [PMID:18313920] |
ChEMBL | Binding affinity at cloned human kappa opioid receptor by [3H]diprenorphine displacement. | B | 8.04 | pKi | 9.2 | nM | Ki | Bioorg Med Chem Lett (2003) 13: 4459-4462 [PMID:14643346] |
ChEMBL | Displacement of [3H]diprenorphine from human cloned kappa opioid receptor expressed in CHO cells | B | 8.04 | pKi | 9.2 | nM | Ki | J Med Chem (2006) 49: 7290-7306 [PMID:17149859] |
ChEMBL | Displacement of [3H]diprenorphine from human cloned kappa opioid receptor expressed in CHO cells | B | 8.04 | pKi | 9.2 | nM | Ki | J Med Chem (2006) 49: 7278-7289 [PMID:17149858] |
ChEMBL | Displacement of [3H]DPN from human recombinant kappa-type opioid receptor expressed in CHO cell membranes | B | 8.35 | pKi | 4.47 | nM | Ki | Bioorg Med Chem (2009) 17: 5080-5095 [PMID:19527931] |
ChEMBL | Displacement of [125I]OXY from human kappa opioid receptor expressed in CHO cells | B | 8.52 | pKi | 3 | nM | Ki | J Med Chem (2010) 53: 1392-1396 [PMID:20055417] |
ChEMBL | Displacement of [3H]U69593 form human kappa opioid receptor expressed in CHO cells | B | 8.92 | pKi | 1.2 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 203-208 [PMID:19027293] |
ChEMBL | Inhibition of [3H]U-69593 binding to human Opioid receptor kappa 1 expressed in HEK 293 cells | B | 8.92 | pKi | 1.2 | nM | Ki | Bioorg Med Chem Lett (2000) 10: 523-526 [PMID:10741545] |
ChEMBL | Displacement of [3H]U-69593 from human opioid kappa receptor expressed in CHO cells | B | 8.96 | pKi | 1.1 | nM | Ki | J Med Chem (2007) 50: 2254-2258 [PMID:17407276] |
ChEMBL | Displacement of [3H]U69563 from human kappa-opioid receptor expressed in CHO cells after 60 mins by scintillation counting | B | 9.6 | pKi | 0.25 | nM | Ki | Bioorg Med Chem (2011) 19: 2808-2816 [PMID:21482470] |
ChEMBL | Antagonist activity at human opioid kappa receptor expressed in CHO cells assessed as inhibition of U-50488-stimulated [35S]GTP-gamma-S binding | F | 6.49 | pIC50 | 320 | nM | IC50 | J Med Chem (2007) 50: 2254-2258 [PMID:17407276] |
ChEMBL | Antagonist activity at human KOR expressed in CHO cell membranes assessed as reduction in U50,488 induced response incubated for 1 hr by liquid scintillation counting based [35S]GTP-gamma-S assay | B | 6.85 | pIC50 | 140 | nM | IC50 | J Med Chem (2016) 59: 10291-10298 [PMID:27797517] |
ChEMBL | DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) | B | 7.12 | pIC50 | 75 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ChEMBL | Antagonistic activity in the Opioid receptor kappa 1-mediated [35S]GTP-gamma-S, binding assay against 50 nM U-50,488 | F | 7.3 | pIC50 | 49.8 | nM | IC50 | J Med Chem (2003) 46: 2104-2109 [PMID:12747782] |
ChEMBL | Binding affinity against opioid receptor kappa 1 using [3H]- U-69,593 radioligand | B | 8.82 | pIC50 | 1.5 | nM | IC50 | J Med Chem (2001) 44: 3378-3390 [PMID:11585443] |
ChEMBL | Agonist activity at human opioid kappa receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding | F | 8 | pEC50 | 10 | nM | EC50 | J Med Chem (2007) 50: 2254-2258 [PMID:17407276] |
ChEMBL | Effective concentration for half-maximal stimulation was determined by [35S]GTP-gamma-S, assay | F | 8.18 | pEC50 | 6.6 | nM | EC50 | J Med Chem (2003) 46: 2104-2109 [PMID:12747782] |
κ receptor/Kappa opioid receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4329] [GtoPdb: 318] [UniProtKB: P33534] | ||||||||
ChEMBL | Antagonist activity at kappa opioid receptor in Swiss mouse vas deferens assessed as reversal of U50488 effect on electrically-induced driven twitch | F | 6.9 | pKd | 125.89 | nM | Kd | Bioorg Med Chem (2008) 16: 869-873 [PMID:17962026] |
κ receptor/Kappa opioid receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3614] [GtoPdb: 318] [UniProtKB: P34975] | ||||||||
ChEMBL | Inhibition against binding of radioligand [N-allyl-2-3-3H]-naloxone to membrane of baby hamster kidney cells infected with forest virus encoding the cDNAs for rat Opioid receptor kappa 1 | B | 8.35 | pKd | 4.5 | nM | Kd | Bioorg Med Chem Lett (2000) 10: 831-834 [PMID:10782696] |
ChEMBL | Compound was evaluated for Opioid receptor kappa 1 affinity against the receptor site model site 4(kappa) | B | 9 | pKd | 1 | nM | Kd | J Med Chem (1986) 29: 531-537 [PMID:3007760] |
Kappa opioid receptor in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3952] [UniProtKB: P41144] | ||||||||
ChEMBL | Tested for its antagonist activity against kappa receptor using U-69,593 as radioligand in isolated guinea pig ileum | F | 7.7 | pKd | 19.95 | nM | Kd | J Med Chem (1994) 37: 2262-2265 [PMID:8057274] |
ChEMBL | Binding affinity towards kappa-opioid receptor by displacement of [3H]-EKC at from guinea pig cortical tissue | B | 7.18 | pKi | 66 | nM | Ki | J Med Chem (1993) 36: 2833-2841 [PMID:8410998] |
ChEMBL | Binding affinity towards kappa opioid receptor by displacement of [3H]EKC in guinea pig cortical tissue | B | 7.18 | pKi | 66 | nM | Ki | J Med Chem (1993) 36: 2842-2850 [PMID:8410999] |
ChEMBL | Tested for binding affinity towards kappa receptor in presence of [3H]EKC radioligand | B | 7.18 | pKi | 66 | nM | Ki | J Med Chem (1994) 37: 2262-2265 [PMID:8057274] |
ChEMBL | Displacement of [3H]Cl-977 from kappa opioid receptor in guinea pig brain membranes after 2 hrs by scintillation counting analysis | B | 7.82 | pKi | 15 | nM | Ki | J Med Chem (2014) 57: 6845-6860 [PMID:25062506] |
ChEMBL | In vivo binding affinity against kappa opioid receptor was measured by using labeled ligand [3H]ethylketocyclazocine (1 nM) with 500 nM DADLE and 20 nM sufentanil | B | 7.92 | pKi | 12 | nM | Ki | J Med Chem (1994) 37: 3121-3127 [PMID:7932535] |
ChEMBL | Displacement of [3H]U-69593 from kappa opioid receptor in guinea pig brain membranes after 2 hrs by scintillation counting analysis | B | 8.14 | pKi | 7.3 | nM | Ki | J Med Chem (2014) 57: 6845-6860 [PMID:25062506] |
ChEMBL | Displacement of [3H]U69593 from kappa opioid receptor in guinea pig brain membrane after 150 mins by scintillation counting | B | 8.14 | pKi | 7.3 | nM | Ki | J Med Chem (2010) 53: 4212-4222 [PMID:20441176] |
ChEMBL | Displacement of [3H]U69593 from kappa opioid receptor in guinea pig brain membranes after 150 mins by scintillation counting | B | 8.14 | pKi | 7.3 | nM | Ki | Eur J Med Chem (2011) 46: 1972-1982 [PMID:21481987] |
ChEMBL | Displacement of [3H]U-69,593 from kappa-type opioid receptor in guinea pig brain membranes after 120 mins by solid scintillation counting | B | 8.14 | pKi | 7.3 | nM | Ki | J Med Chem (2017) 60: 2526-2551 [PMID:28218838] |
ChEMBL | Displacement of [3H]U-69,593 from KOR in guinea pig brain membranes after 120 mins by scintillation counting method | B | 8.14 | pKi | 7.3 | nM | Ki | J Med Chem (2019) 62: 893-907 [PMID:30543421] |
ChEMBL | Displacement of [3H]U69,593 from kappa opioid receptor in guinea pig brain membrane after 120 mins by scintillation counting analysis | B | 8.16 | pKi | 6.9 | nM | Ki | J Med Chem (2019) 62: 4204-4217 [PMID:30939014] |
ChEMBL | Displacement of [3H]-U-69593 from kappa opioid receptor in guinea pig brain membrane after 120 mins by scintillation counting | B | 8.16 | pKi | 6.9 | nM | Ki | Bioorg Med Chem Lett (2015) 25: 5326-5330 [PMID:26411794] |
ChEMBL | Displacement of [3H]U-69593 from kappa-opioid receptor in guinea pig brain membrane | B | 8.16 | pKi | 6.9 | nM | Ki | Bioorg Med Chem (2014) 22: 3316-3324 [PMID:24856182] |
ChEMBL | Displacement of [3H]U-69,593 from kappa opioid receptor in guinea pig brain membranes after 120 mins by scintillation counting analysis | B | 8.16 | pKi | 6.9 | nM | Ki | Medchemcomm (2016) 7: 2368-2380 |
ChEMBL | Affinity to opioid receptor kappa 1 using [3H]U-69593 as radioligand in homogenates of guinea pig brain membranes | B | 8.49 | pKi | 3.2 | nM | Ki | J Med Chem (2001) 44: 2814-2826 [PMID:11495592] |
ChEMBL | Displacement of [3H]U-69593 from kappa opioid receptor in guinea pig brain membrane | B | 8.5 | pKi | 3.17 | nM | Ki | Eur J Med Chem (2007) 42: 1247-1262 [PMID:17420073] |
ChEMBL | Displacement of [3H]U-69,593 from kappa opioid receptor in guinea pig brain membarnes by liquid scintillation counting method | B | 8.51 | pKi | 3.1 | nM | Ki | Medchemcomm (2016) 7: 317-326 |
ChEMBL | Inhibition of opioid receptor kappa by displacing 0.5 nM [3H]bremazocine in guinea pig brain membrane | B | 7.3 | pIC50 | 50 | nM | IC50 | J Med Chem (1992) 35: 4589-4594 [PMID:1335078] |
ChEMBL | Displacement of 0.5 nM [3H]bremazocine from guinea pig brain membrane opioid receptor kappa with 100 nM DAGO and 100 nM DPDPE | B | 7.3 | pIC50 | 50 | nM | IC50 | J Med Chem (1992) 35: 2374-2384 [PMID:1320121] |
μ receptor/Mu opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL233] [GtoPdb: 319] [UniProtKB: P35372] | ||||||||
ChEMBL | Antagonist activity against mu opioid receptor assessed as effect on endomorphin-2-induced calcium response in CHO cells by aequorin luminescence based calcium assay | F | 9.66 | pKd | 0.22 | nM | Kd | J Med Chem (2007) 50: 512-520 [PMID:17266203] |
ChEMBL | Antagonist activity at mu opioid receptor expressed in CHO cells assessed as release of intracellular calcium ions by aequorin luminescence-based calcium assay | F | 9.66 | pKd | 0.22 | nM | Kd | Bioorg Med Chem Lett (2008) 18: 1350-1353 [PMID:18207400] |
ChEMBL | Displacement of [3H]DAMGO from human MOR expressed in HEK293 cells after 60 mins by scintillation counting analysis | B | 6.45 | pKi | 354 | nM | Ki | J Med Chem (2014) 57: 8903-8927 [PMID:25268943] |
ChEMBL | Displacement of [3H]-diprenorphine from human mu opioid receptor expressed in CHO cell membranes incubated for 1 hr by competition radioligand binding assay | B | 7.23 | pKi | 59.5 | nM | Ki | J Med Chem (2020) 63: 7663-7694 [PMID:32530286] |
ChEMBL | Displacement of [3H]-diprenorphine from human mu opioid receptor expressed in CHO cell membranes incubated for 1 hr by micro beta2 scintillation counting method | B | 7.29 | pKi | 51.2 | nM | Ki | ACS Med Chem Lett (2019) 10: 450-456 [PMID:30996778] |
ChEMBL | Displacement of [3H]-diprenorphine from human MOR expressed in CHO cell membranes incubated for 1 hr by scintillation counting method | B | 7.29 | pKi | 51 | nM | Ki | J Med Chem (2020) 63: 2673-2687 [PMID:31834798] |
ChEMBL | Displacement of [3H]diprenorphine human MOR expressed in CHO cell membranes after 1 hr by micro beta2 scintillation counting method | B | 7.37 | pKi | 43 | nM | Ki | ACS Med Chem Lett (2020) 11: 720-726 [PMID:32435376] |
ChEMBL | DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) | B | 8.09 | pKi | 8.06 | nM | Ki | DrugMatrix in vitro pharmacology data |
ChEMBL | Displacement of [125I]-IBNtxA from MOR-1 expressed in CHO cells | B | 8.37 | pKi | 4.23 | nM | Ki | Bioorg Med Chem Lett (2011) 21: 4001-4004 [PMID:21621410] |
ChEMBL | Displacement of [3H]diprenorphine from human cloned mu opioid receptor expressed in CHO cells | B | 8.43 | pKi | 3.7 | nM | Ki | J Med Chem (2006) 49: 7278-7289 [PMID:17149858] |
ChEMBL | Displacement of [3H]diprenorphine from human cloned mu opioid receptor expressed in CHO cells | B | 8.43 | pKi | 3.7 | nM | Ki | J Med Chem (2006) 49: 7290-7306 [PMID:17149859] |
ChEMBL | Inhibition of binding of the non-selective opioid antagonist, [3H]diprenorphine, to cloned human mu opioid receptor | B | 8.43 | pKi | 3.7 | nM | Ki | Bioorg Med Chem Lett (2003) 13: 4459-4462 [PMID:14643346] |
ChEMBL | Displacement of [3H]diprenorphine from human cloned mu opioid receptor | B | 8.43 | pKi | 3.7 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 2006-2012 [PMID:18313920] |
ChEMBL | In vitro binding affinity to human Opioid receptor mu 1 on CHO cell membranes using [3H]diprenorphine displacement. | B | 8.44 | pKi | 3.63 | nM | Ki | J Med Chem (2003) 46: 2104-2109 [PMID:12747782] |
ChEMBL | Displacement of [3H]-naloxone from human mu opioid receptor expressed in CHO-K1 cells by scintillation counting analysis | B | 8.64 | pKi | 2.3 | nM | Ki | J Med Chem (2014) 57: 6845-6860 [PMID:25062506] |
ChEMBL | Displacement of [3H]naloxone from human mu opioid receptor expressed in CHO-K1 cells after 150 mins by liquid scintillation counting method | B | 8.64 | pKi | 2.3 | nM | Ki | Medchemcomm (2016) 7: 317-326 |
ChEMBL | Displacement of [125I]-IBNalA from MOR-1 expressed in CHO cells | B | 8.64 | pKi | 2.27 | nM | Ki | Bioorg Med Chem Lett (2011) 21: 4001-4004 [PMID:21621410] |
ChEMBL | Displacement of [3H]DAGO from mu opioid receptor | B | 8.8 | pKi | 1.6 | nM | Ki | J Nat Prod (1993) 56: 441-455 [PMID:8496700] |
ChEMBL | Binding affinity to mu opioid receptor | B | 8.82 | pKi | 1.5 | nM | Ki | Bioorg Med Chem Lett (2009) 19: 6736-6739 [PMID:19836950] |
ChEMBL | Displacement of [3H]DAMGO from human MOR expressed in HEK293 cells preincubated for 1 hr followed by radioligand addition measured after 1 hr by liquid scintillation counting analysis | B | 8.9 | pKi | 1.26 | nM | Ki | J Med Chem (2015) 58: 9754-9767 [PMID:26632862] |
ChEMBL | Displacement of 2-((1E,3E,5E)-5-(1-Ethyl-3,3-dimethyl-5-sulfoindolin-2-ylidene)-penta-1,3-dien-1-yl)-1-(6-((6-((6S,7R,7aR,12bS)-9-hydroxy-7-methoxy-3-methyl-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinoline-6-carboxamido)hexyl)-amino)-6-oxohexyl)-3,3-dimethyl-3H-indol-1-ium-5-sulfonate,2,2,2-Trifluoroacetate Salt from human MOR expressed in HEK293 cells by Cheng-Prusoff analysis | B | 8.94 | pKi | 1.15 | nM | Ki | J Med Chem (2015) 58: 9754-9767 [PMID:26632862] |
ChEMBL | Binding affinity to mu-opioid receptor (unknown origin) | B | 9 | pKi | 1 | nM | Ki | J Nat Prod (2021) 84: 713-723 [PMID:32870011] |
ChEMBL | Displacement of [125I]OXY from human mu opioid receptor expressed in CHO cells | B | 9.01 | pKi | 0.98 | nM | Ki | J Med Chem (2010) 53: 1392-1396 [PMID:20055417] |
ChEMBL | Displacement of [3H]DAMGO from human opioid gamma receptor expressed in CHO cells | B | 9.1 | pKi | 0.79 | nM | Ki | J Med Chem (2007) 50: 2254-2258 [PMID:17407276] |
ChEMBL |